Bicocca Open Archive

Logo unimib boa
OGGIONI, NORBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.592
EU - Europa 5.412
AS - Asia 3.490
SA - Sud America 128
AF - Africa 33
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 21
Totale 18.708
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.399
SG - Singapore 1.212
DE - Germania 987
RU - Federazione Russa 921
CN - Cina 897
HK - Hong Kong 873
SE - Svezia 850
IE - Irlanda 673
IT - Italia 637
UA - Ucraina 543
GB - Regno Unito 264
CA - Canada 182
FI - Finlandia 135
VN - Vietnam 132
AT - Austria 112
BR - Brasile 111
FR - Francia 104
KR - Corea 79
IN - India 76
DK - Danimarca 67
ID - Indonesia 65
JP - Giappone 42
NL - Olanda 38
TR - Turchia 29
IR - Iran 24
BE - Belgio 21
MY - Malesia 21
PL - Polonia 19
EU - Europa 18
NZ - Nuova Zelanda 17
AU - Australia 15
ZA - Sudafrica 15
CZ - Repubblica Ceca 9
EG - Egitto 9
ES - Italia 7
MX - Messico 7
AR - Argentina 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CL - Cile 4
HR - Croazia 4
HU - Ungheria 4
SA - Arabia Saudita 4
BD - Bangladesh 3
IQ - Iraq 3
KG - Kirghizistan 3
PK - Pakistan 3
RS - Serbia 3
TW - Taiwan 3
A1 - Anonimo 2
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
CH - Svizzera 2
CO - Colombia 2
EC - Ecuador 2
GT - Guatemala 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
NG - Nigeria 2
PH - Filippine 2
PT - Portogallo 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 18.708
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.879
Hong Kong 852
Woodbridge 819
Singapore 791
Chandler 706
Dublin 653
Jacksonville 543
Houston 525
Fairfield 455
Wilmington 446
Frankfurt am Main 445
Dearborn 424
Ashburn 381
New York 278
Milan 253
Princeton 244
Santa Clara 236
Seattle 175
Nanjing 173
Boardman 170
Cambridge 137
Shanghai 117
Vienna 108
Lachine 89
Dong Ket 78
Moscow 74
Altamura 73
Beijing 71
Lawrence 71
Jakarta 61
Guangzhou 60
Nanchang 59
Los Angeles 52
Council Bluffs 49
Fremont 45
Andover 42
Shenyang 42
Grafing 40
Toronto 38
Jinan 36
Jiaxing 34
Chicago 33
Nürnberg 33
San Diego 31
Helsinki 29
Falls Church 26
Ottawa 26
Seoul 25
Tianjin 25
Zhengzhou 25
Daejeon 24
Munich 24
Kunming 23
Mountain View 23
Hangzhou 22
Hebei 22
Pune 22
The Dalles 22
Changsha 21
Brussels 20
Dallas 20
Sacramento 19
Hefei 17
Leawood 16
Nuremberg 16
Rome 15
Ningbo 14
Philadelphia 14
Phoenix 14
Edmonton 13
Huizen 13
Turku 13
Bergamo 12
Carate Brianza 12
London 12
Norwalk 12
Pasir Mas 12
Regensburg 12
Shinjuku 12
Taizhou 11
Auburn Hills 10
Kiev 9
San Francisco 9
San Mateo 9
Yongin-si 9
Cagliari 8
Codroipo 8
Rio de Janeiro 8
São Paulo 8
Tehran 8
Brooklyn 7
Canazei 7
Detroit 7
Tokyo 7
Washington 7
Wuhan 7
Ankara 6
Changchun 6
Düsseldorf 6
Fuzhou 6
Totale 12.731
Salva come PNG Salva come JPEG
Nome #
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 350
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 324
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 318
Age-related changes in the function and structure of the peripheral sensory pathway in mice 316
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 310
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 263
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 261
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 244
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 243
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 242
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 239
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 227
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 227
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 225
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 221
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 216
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 213
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 213
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 209
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 207
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 206
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 206
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 205
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 203
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 202
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 200
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 197
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 197
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 194
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 191
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 186
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 180
Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor 179
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 179
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 179
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 178
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 176
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 175
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 174
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 171
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 171
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 171
Lipoplatin tm: a less neurotoxic formulation of cisplatin 170
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 170
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 169
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 167
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 167
Erythropoietin both protects from and reverses experimental diabetic neuropathy 166
Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration 165
Granulocytes in actively induced Lewis rat EAE 164
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 163
Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis 162
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 159
Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis 159
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 159
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 155
Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis 154
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 154
Actively induced EAE in Lewis rats: Characterization of spleen and spinal cord infiltrating lymphocytes by flow cytometry during the course of the disease 153
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 152
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 152
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 150
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 150
Multimodal experimental approach to the study of human neurological diseases 150
Characterization of spleen and spinal cord infiltrating lymphocytes during actively induced EAE in Lewis rats. 149
Regression of diabetic complications by islet transplantation in the rat 148
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 148
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 148
Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy 145
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 142
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 141
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 141
Effect of proteasome inhibition on the central and peripheral nervous system 140
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 140
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats 139
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 138
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 138
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 136
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 135
Effect of different chronic treatment modalities on the peripheral neurotoxicity of sagopilone in rats: a multimodal analysis 133
Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis 132
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 130
Functional recovery with syngeneically transplanted microcapsulated pancreatic islets in streptozotocin-induced diabetic rats. 127
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 127
Characterization of Glutamate Transporters in Peripheral Nervous System. 126
Biodistrubution and toxicology of two PFCs intravenously injected in rats 123
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 122
Effects of palmitoylethanolamide (pea) in cisplatin-induced peripheral neuropathy in mice. 122
Neurotoxicity and neuropatic pain induced by Bortezomib:evaluation of peripheral nerve fibres from a clinical to an ultrastructural level 121
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 118
Neurotoxicity ad neuropathic pain induced by Bortezomib: evaluation of peripheral nerve fibres from a clinical to an ultrastructural level. 117
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 114
Evaluation of the neuroprotective effect of acetyl-l-carnitine in myeloma-bearing mice treated with bortezomib 112
STUDY OF THE CALCITONIN GENE-RELATED PEPTIDE-POSITIVE INTRAEPIDERMAL NERVE FIBERS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY 111
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 111
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 111
CHARACTERIZATION OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC CISPLATIN ADMINISTRATION IN SEVERAL MICE MODELS 109
L-serine supplementation suppresses the formation of neurotoxic deoxysphingolipids and improves neuropathy in a type 1 diabetic rat model 109
Different strains of mice are differently susceptible to cisplatin-induced painful peripheral neuropathy (cipn): role of pharmacogenomics? 109
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 109
Totale 17.319
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.663
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202034 0 0 0 0 0 0 0 0 0 0 0 34
2020/20212.346 128 76 259 252 205 197 265 197 205 194 132 236
2021/20221.395 81 139 137 127 96 142 65 76 57 116 102 257
2022/20232.668 297 735 235 260 199 431 34 139 214 30 52 42
2023/20242.035 65 62 79 67 274 536 351 89 101 40 23 348
2024/20254.347 283 607 355 210 350 119 203 169 477 616 416 542
Totale 19.611